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Objective: The matricellular protein NOV/CCN3, is implicated in osteoarthritis (OA) and targeted muta-
tion of NOV in mice (Novdel3) leads to joint abnormalities. This investigation tested whether NOV is
required for joint homeostasis and if its disruption causes joint degeneration.
Method: NOV expression in the adult mouse joint was characterized by immunohistochemistry. A
detailed comparison of the joints of Novdel3/ and Novdel3þ/þ (wild-type) males and females at 2, 6 and
12 months of age was determined by X-ray, histology and immunohistochemistry.
Results: NOV protein was found in speciﬁc cells in articular cartilage, meniscus, synovium and ligament
attachment sites in adult knees. Novdel3/ males exhibited severe OA-like pathology at 12 months
(OARSI score 5.0 ± 0.5, P < 0.001), affecting all tissues of the joint: erosion of the articular cartilage,
meniscal enlargement, osteophytic outgrowths, ligament degeneration and expansion of ﬁbrocartilage.
Subchondral sclerosis and changes in extracellular matrix composition consistent with OA, were also
seen. The density of articular cartilage cells in Novdel3þ/þ knee joints is maintained at a constant level
from 2 to 12 months of age whereas this is not the case in Novdel3/mice. Compared with age and sex-
matched Novdel3þ/þ mice, a signiﬁcant increase in articular cartilage density was seen in Novdel3/
males at 2 months, whereas a signiﬁcant decrease was seen at 6 and 12 months in both Novdel3/males
and females.
Conclusion: NOV is required for the maintenance of articular cartilage and for joint homeostasis, with
disruption of NOV in ageing Novdel3/ male mice causing OA-like disease.
© 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
An impaired ability to maintain homeostasis of the joint is
associated with tissue degeneration, yet the mechanisms that
regulate this process are largely unknown. Failure to maintain
healthy articular cartilage cells is a common feature of ageing and
an important underlying cause of osteoarthritis (OA)1. The associ-
ation of OA with impaired joint homeostasis suggests common
regulators in the pathways mediating these processes.
NOV (CCN3) is a member of the CCN family of matricellular
proteins which have important roles in development, wound
healing, angiogenesis and disease. In skeletal development and
disease CTGF (CCN2) is required for coordinating chondrogenesis
and angiogenesis2, WISP1 (CCN4) is upregulated in OA3 and: C.A. Boulter, School of Bio-
iff CF10 3AX, UK. Tel: 44-
er).
r Ltd and Osteoarthritis Research S
A, Boulter CA, Targeted mu
d Cartilage (2015), http://dx.dmutations in WISP3 (CCN6) cause progressive pseudorheumatoid
dysplasia4, while NOV (CCN3) has roles in skeletal development5,
regulation of osteogenesis6,7, bone regeneration8 and bone can-
cer9. All CCN proteins share a common modular structure: an
insulin-like growth factor binding protein (IGFBP) domain, a von
Willibrand factor type C (WVC) domain, a thrombospondin type 1
repeat (TSP1) and a carboxy-terminal (CT) domain containing a
cysteine knot (absent in CCN5). By speciﬁc interactions with these
domains, CCN proteins modulate multiple signalling pathways
including BMPs, Wnt, TGFs, Notch and integrins to regulate cell
proliferation, survival, adhesion, migration and differentiation10.
Recent work has implicated NOV in OA. In experimentally
induced OA in mice elevated NOV expression is seen in gene array
studies using RNA isolated from arthritic joints11. Similarly, in hu-
man OA NOV is upregulated12. This may reﬂect a role for NOV in OA
pathology or alternatively, that NOV is induced in response to joint
damage and acts to mediate repair. Indeed, studies comparing OA
susceptible and non-susceptible rat strains have identiﬁed NOV as a
potential gene conferring protection from OA13.ociety International. This is an open access article under the CC BY license (http://
tation of NOV/CCN3 in mice disrupts joint homeostasis and causes
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targetedmutationNovdel3 revealed joint abnormalities in addition to
othermild skeletal phenotypes5. In this paper, we have performed a
detailed investigation of the role of NOV in the adult joint. We have
characterized the expression pattern of NOV in the adult knee joint,
and show that homeostasis of articular cartilage cells is compro-
mised in the Novdel3/ mutants, and that 12 month Novdel3/
males exhibit joint degeneration with an OA-like pathology.
Materials and methods
Experimental animals
Male and female Novdel3/ mice carrying a targeted mutation
in Nov5 and wild type littermates (Novdel3þ/þ) were maintained on
a 129Sv background. Breeding and analysis of mice were approved
by the Cardiff University's Ethical Committee and performed in
accordance with the Animal [Scientiﬁc Procedures] Act 1986 under
project licences PPL 30/2672, PPL 30/2600. Mice housed together
on a 12-h lightedark cycle with a temperature range of 21C ± 2,
with free access to tap water and standard chow.
X-ray imaging and skeletal preparation
Novdel3þ/þ and Novdel3/ male and female adult mice were
ﬁxed by perfusion with 4% paraformaldehyde (PFA) in PBS at 2, 6
and 12months (n¼ 6 for each sex and genotype at each time point).
The hind limbs were dissected and imaged by X-ray (KODAK In-Vivo
Imaging System FX Pro) prior to decalciﬁcation in 10% EDTA pH 7.
7 mm coronal parafﬁn sections were prepared semi-serially.
Histological assessment and OARSI score
Comparable sections from each animal, stained using haema-
toxylin and eosin (H&E), toludine blue and safranin O were
assessed for histopathological changes (by KR blinded to genotype),
using the OARSI scheme14 (see Supplementary Methods), assigning
a score between 0 and 6 to all four quadrants averaged over three
sections (n ¼ 6 of each sex and genotype at each time point). OA
severity is expressed as the summed score across the entire joint.
Collagen birefringence in the tibial plateau (two sections, n ¼ 4 for
each sex and genotype at each time point) was imaged by polarized
light microscopy (Polarisation equipped Zeiss Photomicroscope).
Analysis of articular cartilage cell density and thickness
Articular cartilage cell density was determined for each of the
four quadrants of the joint from four H&E sections per animal (n¼ 4
for each sex and genotype at each time point) (KR blinded to geno-
type). Cell number and area of articular and calciﬁed cartilage were
measured within a box of 0.32  0.23 mm placed on load-bearing
regions of articular cartilage. Cartilage thickness, measured at
three equidistant points across the cartilage on both themedial and
lateral side of the tibia, was averaged across a minimum of three
sections (n ¼ 4 for each sex and genotype at each time point).
Immunohistochemistry
Anti-NOV rabbit polyclonal antibody Novpep5170 (Pepceuticals
Ltd), against peptide CPQNNEAFLQDLELKTSRGEI, was used to
analyse expression in 6 month Novdel3þ/þ and Novdel3/ males
and females (n ¼ 3 for each genotype and sex). Cell proliferation
and apoptosis were analysed at 2, 6 and 12 months using a rabbit
polyclonal to PCNA (Abcam) and PARP p85 (Promega), (n ¼ 4 for
each genotype, sex and stage). The percentage positive cells wasPlease cite this article in press as: Roddy KA, Boulter CA, Targeted mu
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KR blinded to genotype. Collagen I and Collagen X expression was
assayed using mouse monoclonals anti-ColI (1/1000, Sigma) and
anti-ColX (1/10, gift of Klaus von der Mark) (n ¼ 4 for each geno-
type, sex and stage). Immunohistochemistry details in
Supplementary Methods.
Statistical analysis
The effects of genotype, sex and age on measurements of
articular cartilage histological (OARSI) score, thickness and cell
density, and chondroctye proliferation/apoptosis were tested using
three way ANOVA (SPSS) and included analysis of both simple and
main effects. Normality was checked using the ShapiroeWilk test
and homogeneity of variances was veriﬁed using Levene's test
(SPSS).
Results
NOV is expressed in the adult knee joint
NOVwas detected by immunohistochemistry in multiple tissues
of male and female knee joints: the synovial intima, a membrane
lining all the non-articular structures in the joint [Fig.1(A), (B), (N)];
the superﬁcial layer of the articular cartilage, particularly at the
extremities of the joint e.g., near the cruciate ligament [Fig. 1(A), (B)
arrowhead, L]; a subset of cells in the calciﬁed cartilage [Fig. 1(A),
(D) (arrow), L]; the outmost layer of cells in the meniscus [Fig. 1(A)]
and a subset of cells in the core [Fig. 1(A), (C) (arrow), M]; the sy-
novial lining over the femur and in a thin layer lining the inner
surface of the adjacent collateral ligament [Fig. 1(E)]; the patella, in
large round cells at the ﬁbrocartilage attachment sites of the
capsular ligaments [Fig. 1(F), (G), (O)]. No signal was detected in
Novdel3/ mice [Fig. 1(H)e(K)].
Novdel3/ mice exhibit joint defects with features characteristic
of OA
Todetermine theeffect ofNOVexpressionon the gross anatomyof
the knee joint,Novdel3/males and females were analysed by X-ray
at 2, 6 and 12months of age and comparedwith age and sexmatched
Novdel3þ/þ littermates (n ¼ 6 for each group) [Fig. 2(A)e(C)]. While
the structure of the female joint at all time points appeared overtly
normal (not shown), the Novdel3/ males displayed a number of
pathological changes compared with Novdel3þ/þ males [Fig. 2(B),
(C)]. The menisci of 12 month Novdel3/ males (4/6) were abnor-
mally largewith regions of calciﬁcation adjacent to the knee [Fig. 2(C)
arrowhead], as previously noted in Ref. 5. While normal at 2 months
[Fig. 2(A)], early stages of meniscal enlargement could already be
seen at 6 months (1/6) [Fig. 2(B) arrowhead]. At 12 months, osteo-
phytes were seen, particularly on the tibia [Fig. 2(C)] and the femoral
epicondyle also appeared enlarged [Fig. 2(C)] (4/6).
Histological analysis was performed by toluidine blue staining
of cartilage extracellular matrix (ECM) and H&E staining of coro-
nal sections of the knees isolated from Novdel3/ and Novdel3þ/þ
males and females at 2, 6 months and 12 months of age (n ¼ 6 for
each group) (Fig. 2). Novdel3/ female mice were comparable to
Novdel3þ/þ controls at 2, 6 and 12 months, with both showing
slight reductions in toluidine blue staining at 12 months [Fig. 2(D)
arrowhead]. The number of articular cartilage cells at 6 and 12
months appeared reduced compared to Novdel3þ/þ females, with
evidence of cell remnants near the articular surface [Fig. 2(E)]. In
contrast, the joints of Novdel3/ males were clearly abnormal
[Fig. 2(F)e(H)]. Toluidine blue staining of cartilage ECM was
increased in 2month Novdel3/males compared with Novdel3þ/þtation of NOV/CCN3 in mice disrupts joint homeostasis and causes
doi.org/10.1016/j.joca.2014.12.012
Fig. 1. Immunohistochemical characterization of NOV expression in 6 month males (AeK) and females (LeO). NOV is expressed in the most superﬁcial layer of the articular cartilage
at margins of the joint and meniscus (A, B, arrowhead), the synovial intima (A, B) and a subset of cells in the calciﬁed layer (A, D, arrow) and meniscus (B). NOV is also present in the
synovial lining of the femur and lining the collateral ligaments (E), and in the attachment site of the ﬁbrous capsule (fc) to the patella (F, G). No signal was detected in Novdel3/
ﬁbrous capsule (H, I), meniscus (J) or articular cartilage (K). In females NOV is also expressed in the superﬁcial layer (L, arrowhead), the synovial intima (N), a subset of cells in the
calciﬁed layer and meniscus (L, M) and the patella (O). Scale bars are 100 mm unless indicated. tib; tibia, m; meniscus, s; synovium, fem; femur, ac; articular cartilage, tl; tideline, cc;
calciﬁed cartilage, l; collateral ligament, pat; patella.
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articular cartilage cells also seen [Fig. 2(G)]. However, at 6 and 12
months toluidine blue staining was reduced in Novdel3/ males
compared to Novdel3þ/þ controls [Fig. 2(F)], consistent with the
depletion of articular cartilage cells also observed [Fig. 2(G)]. Six-
month-old Novdel3/ males also showed distinct ﬁbrillation of
the articular surface [Fig. 2(F), (G)] and by 12 months the male
joint was badly compromised [Fig. 2(F), (H)]. Severe pathological
changes included loss of ECM staining [Fig. 2(F)], cracks in the
articular surface, loss of chondrocytes and loss of the articular
surface, with exposure of bone and damage to the meniscus
[Fig. 2(H)]. Enlarged menisci with peripheral marrow cavities
were present in 12 month Novdel3/males [Fig. 2(H)]. Abnormal
ﬁbrocartilage-like tissue was also found around the knee joint in
spaces normally occupied by synovium or collateral ligaments.
Subchondral sclerosis was evident at 12 months in Novdel3/
males, but not in Novdel3þ/þmales [Fig. 2(I)] or in females of either
genotype (data not shown). In summary, the pathological changes
observed in the Novdel3/males were consistent with an OA-like
phenotype.
To determine the severity of OA in the Novdel3/ mice, the
OARSI grading scheme14 was used. No pathological changes were
apparent at 2 months in Novdel3/ or Novdel3þ/þmales or females
(OARSI score of 0, data not shown). No signiﬁcant changes in the
OARSI scores were observed between Novdel3/ mice and sex-
matched controls at 6 months. However, at 12 months Novdel3/
males, but not females, showed signiﬁcantly higher OARSI scores
(Fig. 3; OARSI score 5.0 ± 0.5, P < 0.001), indicating severe OA-like
joint pathology. The OARSI score of the 12 month Novdel3/males
was also signiﬁcantly higher than those of the 6 month Novdel3/
males (P < 0.001) and 12 month Novdel3/ females (P < 0.001). No
signiﬁcant differences were seen between the Novdel3þ/þ males
and females.Please cite this article in press as: Roddy KA, Boulter CA, Targeted mu
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mice
SafraninO and toluidine blue staining revealed that proteoglycans
characteristic of cartilagewere present inmultiple ectopic sites in the
joints of 12 month Novdel3/males, indicating inappropriate carti-
lage differentiation in these tissues, but not in Novdel3/ females
and Novdel3þ/þ control mice of either sex. Increased safranin O
staining was found at multiple sites in the enlarged menisci of
Novdel3/ males, particularly at the periphery [Fig. 4(A)], in the sy-
novial intima lining the femur [Fig. 4(A),*], in the collateral ligament
and throughout the femoral notch [Fig. 4(B)], an area normally
occupied by the cruciate ligaments. In the ligaments, proteoglycan
changes ranged from abnormal safranin O staining near the insertion
sites to complete degeneration of the cruciate ligament and its
replacement with extensive safranin O stained ﬁbre-like structures
[Fig. 4(B)], possibly indicating cartilage metaplasia in the ligament.
Osteophytes, expressing the osteoblast marker alkaline phosphatase,
were also found inNovdel3/malemice at 12months [Fig. 4(C), (D)]
and inmales at 6months, but not inNovdel3þ/þmales or in females of
either genotype (data not shown). Abnormal clusters of proliferating
cells were present in themeniscus ofNovdel3/males at 12months
but not in Novdel3þ/þ male littermates, based on immunohisto-
chemistrywith an anti-PCNA antibody [Fig. 4(E)]. Increased numbers
of PCNA positive cells were also identiﬁed in the synovial intima over
the femur and in the collateral ligaments [Fig. 4(E)] and cruciate
ligament (not shown) of Novdel3/ males. This suggests that NOV
mutation is associated with ectopic cell proliferation in joint tissues
with an OA-like pathology.
Articular cartilage cell density and thickness is altered in Novdel3/
mice
Initial observations of H&E stained sections indicated differences
in the density of articular cartilage cells inNovdel3/mice [Fig. 2(E),tation of NOV/CCN3 in mice disrupts joint homeostasis and causes
oi.org/10.1016/j.joca.2014.12.012
Fig. 2. X-ray and histological analysis of Novdel3/ and Novdel3þ/þ knee joints. AeC: X-rays of 2, 6 and 12 month male Novdel3/ joints revealed abnormal bone (B, C, arrowhead),
osteophytes (C,*), enlarged epicondyles (C, arrow), whereas male Novdel3þ/þ joints were normal. Knee joints of both Novdel3/ and Novdel3þ/þ females were normal (data not
shown). DeG: Histological analysis of 2, 6 and 12-month-old Novdel3/ and Novdel3þ/þ females (D, E) and males (F, G) by staining with toluidine blue (D, F) and H and E (E, G).
Normal toluidine blue staining of Novdel3/ females compared with controls (D), but H and E staining showed decreased articular cartilage cell densities at 2, 6 and 12 months (E)
with cell remnants (cr) present at 6 and 12 months (E) (see inserts). Compared to age and sex matched controls, Novdel3/ male joints had reduced toluidine blue staining (F),
depleted articular cartilage cell density and articular damage at 6 and 12 months (G) with ﬁbrillation (f) at 6 and 12 months. H: H and E staining of Novdel3/ and Novdel3þ/þmales
at 12 months showing signiﬁcant joint pathology in the mutant with erosion (e), clefts (c), enlarged (em) or damaged (dm) meniscus (m), cruciate ligament (cl) degeneration and
ﬁbrocartilage expansion (*) in the joint margins and subchondral sclerosis (ss). I: 12 month males showed distinct subchondral sclerosis (ss) with loss of marrow cavities (mar). tib;
tibia, fem; femur, ac; articular cartilage, cc; calciﬁed cartilage, tm; tidemark. Scale bar 1 mm (AeC), 100 mm (D, F, H) and 50 mm (E, G).
K.A. Roddy, C.A. Boulter / Osteoarthritis and Cartilage xxx (2015) 1e94(G)]. To quantify this, themean density of articular chondrocyteswas
determined for the medial and lateral compartments of the femur
and tibia at each time point and the overall mean used for analysis
(n ¼ 4 mice of each genotype and sex at each time point). Articular
cartilage cell density is maintained at a constant level in Novdel3þ/þ
mice over the timescale 2e12 months [Fig. 5(A)]. In contrast, this is
not seen in Novdel3/mice. Compared to aged matched Novdel3þ/þ
males, a signiﬁcant increase in articular cartilage cell density was
found inNovdel3/males at 2months (P < 0.001) while a signiﬁcant
decrease was seen at 12 months (P < 0.001) [Fig. 5(A)]. Articular
cartilage cell densities were also signiﬁcantly reduced in Novdel3/Please cite this article in press as: Roddy KA, Boulter CA, Targeted mu
osteoarthritis-like disease, Osteoarthritis and Cartilage (2015), http://dx.females at 6months (P¼ 0.004) and 12months (P¼ 0.006) compared
with age matched Novdel3þ/þ females [Fig. 5(A)].
The mean thickness of the articular cartilagewas also measured,
in order to determine whether this might account for the alter-
ations in cell density [Fig. 5(B)]. In 12-month-old Novdel3/males,
a signiﬁcant increase in articular cartilage thickness was observed
(P < 0.001). However, compared to sex and aged matched controls,
no signiﬁcant differences were observed in Novdel3/ females at
any timepoint and in Novdel3/ males at 2 and 6 months, indi-
cating that other factors contributed to the early cell density
changes seen in these mice.tation of NOV/CCN3 in mice disrupts joint homeostasis and causes
doi.org/10.1016/j.joca.2014.12.012
Fig. 3. Mean OARSI score of the knee joints of Novdel3/ and Novdel3þ/þ males and
females at 6 and 12 months (n ¼ 6 of each sex and genotype at each time point), (±95%
CI), P values indicated.
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much less severely affected, with no signiﬁcant changes to the
overall thickness, comparing Novdel3/ and Novdel3þ/þ age and
sex-matched mice at 2, 6 and 12 months [Supplementary Fig. 1(A)].
Interestingly, at 2 months calciﬁed cartilage was signiﬁcantly
thinner in males of both genotypes than in females and older males
(P < 0.001). Similarly, no signiﬁcant changes in chondrocyte cell
density were seen in the calciﬁed cartilage of Novdel3/ and
Novdel3þ/þ sex matched mice at 6 and 12 months [SupplementaryFig. 4. Histological changes at 12 months in knee joints of Novdel3/males compared with N
articular cartilage (ac), collateral ligament (l), cruciate ligament (cl) and synovium (*) (A, B).
and cruciate ligament (cl) (arrowheads) (B). C: H and E staining of joint margins showing the
control. D: Alkaline phosphatase staining of adjacent section shown in C. Positive staining
Immunohistochemistry with anti-PCNA antibody, counterstained with haematoxlyin. Prolife
(s) and in the groups of cells in the margins of the meniscus in Novdel3/ males. Negative
Please cite this article in press as: Roddy KA, Boulter CA, Targeted mu
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Novdel3/males (P < 0.001). Thus, the calciﬁed cartilage appears
less severely affected byNovmutation than is the articular cartilage.Altered cell proliferation and cell death in Novdel3/ mice
To determine whether articular cartilage cell density changes
might reﬂect altered apoptosis or cell proliferation, immunohisto-
chemistry for the apoptosis marker PARP p85 [Fig. 5(C)] and the
proliferation marker PCNA [Fig. 5(D)] was performed. A signiﬁcant
increase in the percentage of PARP p85 and signiﬁcant decrease in
the percentage of PCNA positive cells were observed in 6-month-
old females (P < 0.001 and P ¼ 0.01, respectively), indicating that
increased apoptosis and decreased proliferation contribute to the
decrease in articular cartilage cell density of Novdel3/ females at
this time point [Fig. 5(C), (D)]. However, this was not observed in
12-month-old Novdel3/ females where no signiﬁcant difference
was seen in the percentage of apoptotic cells and a signiﬁcant in-
crease (P < 0.014) in proliferation was apparent compared to con-
trol mice, despite a decrease in articular cartilage cell density. No
signiﬁcant differences were seen in the percentage of PCNA or PARP
p85 positive cells in 2, 6 and 12 month Novdel3/males compared
to Novdel3þ/þ males, indicating that altered rates of cell prolifera-
tion or apoptosis could not account for the cell density differences
observed in these mice [Fig. 5(C), (D)].Abnormal ECM in Novdel3/ mice characteristic of OA
Speciﬁc changes to the distribution of ECM molecules in artic-
ular cartilage are indicative of OA, including altered collagen ﬁbre
structure15 and aberrant expression of collagen I and collagen X15.
We determined the structure of collagen in articular cartilage of 6
month Novdel3/ and Novdel3þ/þ mice by picrosirus red stainingovdel3þ/þmales. A, B: safranin O staining. Increased staining seen in the meniscus (m),
Note expansion of ﬁbrocartilage stained with safanin O in the collateral ligament (l) (A)
presence of osteophytic outgrowths (op) in Novdel3/males (C), but not in Novdel3þ/þ
of the osteophytes with the osteoblast marker alakaline phosphatase (AlkPhos) (D). E:
rating cells expressing PCNA (black arrowhead) were found in ligaments (l), synovium
cells indicated by white arrow. Scale bar 100 mm.
tation of NOV/CCN3 in mice disrupts joint homeostasis and causes
oi.org/10.1016/j.joca.2014.12.012
Fig. 5. Histological analysis of articular chondrocytes in Novdel3/ and Novdel3þ/þ knee joints at 2, 6 and 12 months. A: Chondrocyte density measurements (n ¼ 4 at each age,
genotype and sex). B: Cartilage thickness (n ¼ 4 at each age, genotype and sex). C: Percentage of cells positive for immunohistochemical staining with anti-PARP p85 antibody
apoptotic marker (n ¼ 4 at each age, genotype and sex). D: Percentage of cells positive for immunohistochemical staining with anti-PCNA antibody proliferation marker (n ¼ 4 at
each age, genotype and sex). No PARP p85 positive cells were detected at 2 months (data not shown). Graphs depict mean (±95% CI), P values indicated.
K.A. Roddy, C.A. Boulter / Osteoarthritis and Cartilage xxx (2015) 1e96and polarised light microscopy (n ¼ 4 for each sex and genotype).
Brighter and strikingly thicker collagen ﬁbril structure was seen in
Novdel3/ males compared with Novdel3þ/þ males [Fig. 6(A)].
In contrast, no obvious structural changes were apparent in
Novdel3/ females compared with controls [Fig. 6(B)].
Collagen X is a marker of hypertrophy in chondrocytes and is
normally restricted in the joint to the thin layer of calciﬁed cartilage
below the tidemark. However in OA, collagen X is expressed in cells
above the tidemark16,17, consistent with abnormal differentiation of
articular cartilage cells down the endochondral pathway. Immu-
nohistochemistry using an anti-collagen X antibody gave the ex-
pected pattern of expression in knee joints in Novdel3þ/þmales and
females at 6 and 12 months [Fig. 6(C), (D); data not shown].
Novdel3/ females at 6 and 12months also expressed collagen X as
normal (data not shown). In contrast, in joints of Novdel3/males,
the normal expression of collagen X at the tidemark was disrupted
[Fig. 6(C), (D)] and was also present near areas of obvious cartilage
damage [Fig. 6(C), (D)], consistent with an OA-like pathology.
Collagen I is normally expressed in the superﬁcial layer of the
articular cartilage and its expression increases in areas ofPlease cite this article in press as: Roddy KA, Boulter CA, Targeted mu
osteoarthritis-like disease, Osteoarthritis and Cartilage (2015), http://dx.damage17e19. As expected, Novdel3þ/þ males at 6 and 12 months
showed normal collagen I localization [Fig. 6(E), (F)]. In contrast, 6
and 12 month Novdel3/ males exhibited stronger collagen I
staining in the articular cartilage surface layer and in areas of visible
cartilage damage [Fig. 6(F)].
Discussion
This is the ﬁrst detailed characterization of the joint phenotype
in Novdel3 mutant mice and identiﬁes NOV as a new regulator of
joint homeostasis with a role in OA. Homeostasis of articular
cartilage is crucial to joint health. Here we show that the density of
articular cartilage cells is normally maintained at a constant level in
adult 129Sv mice between 2 and 12 months of age, whereas, this
homeostatic process is compromised in Novdel3/ mutants.
Novdel3/ females exhibited depletion of articular cartilage cell
density compared to age matched Novdel3þ/þ females at 6 and 12
months; at 6 months this was due, at least in part, to decreased
proliferation and increased apoptosis. In contrast, altered prolifer-
ation and apoptosis could not account for the large variation seen intation of NOV/CCN3 in mice disrupts joint homeostasis and causes
doi.org/10.1016/j.joca.2014.12.012
Fig. 6. Collagen content and distribution in articular cartilage of knee joints of Novdel3/ mice and Novdel3þ/þ mice. A, B: Collagen birefringence, captured from picrosirus Red
stained sections of 6 month males (A) and females (B) imaged under polarized light. Thicker collagen ﬁbres seen in Novdel3/ males compared with Novdel3þ/þ males (A, white
arrows) but not in Novdel3/ females (B). CeF: Immunohistochemistry with anti-collagen X (C, D) and anti-collagen I antibodies (E, F) of Novdel3/ and Novdel3þ/þmale articular
cartilage at 6 (D, E) and 12 months (D, F). In Novdel3þ/þ, collagen X is adjacent to the tidemark (tm) (A, B, arrows) and collagen I is in the superﬁcial articular cartilage (C, D, arrows).
Aberrant expression of collagen I and collagen X in Novdel3/ males at 6 and 12 months is indicated by arrowheads (CeF). Scale bar 100 mm.
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compared with age-matched Novdel3þ/þ males, a signiﬁcant
depletion in cell density was seen at 12 months, whereas a dra-
matic increase was observed at 2 months. This suggests that dif-
ferences in the density of articular chondrocytes in Novdel3/
males have a different underlying origin, possibly reﬂecting
changes in development or in behaviour of articular cartilage cells
or their progenitor populations, as discussed below. Thus, normal
NOV function is essential for maintenance of articular cartilage cell
density in adult mice in the ﬁrst year of life.
Multiple lines of evidence indicate loss of normal NOV function
in Novdel3/ males leads to OA-like joint pathology. Moderate
pathological changes are present in 6 month Novdel3/males and,
by 12 months, severe joint pathology is seen, reﬂected in a high
OARSI score. Subchondral bone is less severely affected with sub-
chondral sclerosis, but little effect on the calciﬁed cartilage.
Collagen X positive cells near damaged articular surfaces indicate
aberrant differentiation of articular chondrocytes, also seen in OA16.
In Novdel3/mice, clusters of cells in the margins of the meniscus
and in the synovium express the proliferation marker PCNA,
consistent with the expansion of these tissues. Severe disruption of
the knee joint is apparent at 12 months in Novdel3/ males with
osteophytes, degenerate ligaments, enlargedmenisci and abnormal
proteoglycan content. The worst cruciate ligament degeneration is
associated with the presence of the largest menisci and most
osteophytes. Abnormal ligaments and menisci would signiﬁcantly
alter the distribution of load across the joint, leading to changes in
gene expression in the mechanically sensitive cartilage and liga-
ments. Abnormal loading of the joint is a key factor in the pro-
gression and severity of OA20e22 and is likely to be a contributing
factor in the early onset OA-like pathology seen in the Novdel3/
mice. Moreover, joint laxity has also been observed in Novdel3/
mice, correlating with the expression of NOV in mechano-
responsive ligament attachment sites and tendons5. The
meniscus, important in correct load transmission and abnormal in
Novdel3/males, is also a site of NOV expression. Indeed, NOV has
been shown to be regulated by mechanical stress23. The expression
of NOV in a subset of cells in joint tissues may reﬂect several pa-
rameters including differentiation, cell cycle status or mechanical
load. Thus, the aberrant behaviour of joint tissues in Novdel3/
mice may result directly from NOV mutation, rather than being
solely a consequence of abnormal joint structure and biomechanics.Please cite this article in press as: Roddy KA, Boulter CA, Targeted mu
osteoarthritis-like disease, Osteoarthritis and Cartilage (2015), http://dx.dWhilst joint defects have not previously been reported in another
NOVmouse mutant7, this may reﬂect differences in the mutation or
strain in the proclivity of mice to develop OA-like pathology.
The ECM of the articular cartilage in Novdel3/ male mice was
also signiﬁcantly different at 6 months, with decreased levels of
proteoglycans and increased collagen ﬁbre thickness compared to
age and sex-matched littermates. Consistent with this, NOV has
been reported to promote sulphated proteoglycan synthesis in
chondrocytes isolated from developing rat epiphysis24. It would be
of interest to determine whether ECM proteins that regulate
collagen ﬁbril size and diameter, such as decorin and collagen IX are
altered in the Novdel3/mice. NOV has been shown to bind to
ﬁbrillin-1, and, is over expression in Tsk mice is associated with
increased ﬁbrillin-1 expression and repression of microﬁbril as-
sembly25. Given that ﬁbrillin-1 has recently been implicated in
OA26, it would also be of interest to determine whether ﬁbrillin-1
staining in the mutant is affected.
The observation that male Novdel3/ mice are more affected
than age-matched females is consistent with other mouse models
of OA27. The higher incidence of spontaneous OA in male mice has
been linked directly to the action of male hormones in exacerbating
OA pathology27 and the protective role of female hormones28,
suggesting that there may be a regulatory network involving sex
hormones that inﬂuences OA severity. The androgen receptor has
recently been shown to inhibit the Nov promoter via epigenetic
silencing29. The increased susceptibility of Novdel3/males to OA
cannot be explained through the androgen inhibition of the Nov
promoter, but it may suggest that in mice NOV is part of a wider
regulatory network involving sex hormones that leads directly or
indirectly to increased OA susceptibility.
NOV has previously been linked to OA through its increased
expression demonstrated in micro-array studies in mouse11 and in
man12 suggesting a role for NOV in OA processes. We believe that
these results can be reconciled with ours by the hypothesis that
NOV is induced in damaged tissue in OA and plays a role in healing.
Indeed, a role for NOV in tissue regeneration has been reported in
the skin30 and tooth31. Articular cartilage is normally very limited in
its ability to heal and it appears that this is further compromised in
Novdel3/ mice. Cartilage homeostasis and repair is thought to
involve expansion and differentiation of progenitor cell pop-
ulations; putative stem/progenitor cells are located in the syno-
vium32 and in the superﬁcial layer of the articular cartilage33,34 andtation of NOV/CCN3 in mice disrupts joint homeostasis and causes
oi.org/10.1016/j.joca.2014.12.012
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from below the tidemark in late stage OA35. These cells are capable
of differentiating and some have been shown respond to damage
and to attempt healing33. Expression of NOV in the articular carti-
lage superﬁcial layer and synovium suggests that it might inﬂuence
the behaviour of the progenitor cells located there. Indeed, a role
for NOV in regulating precursor cells has been shown in other
systems31,36,37. It will be of interest to determine whether the al-
terations in articular chondrocyte density seen in Novdel3/ mice
is due to abnormal progenitor cell function; abnormal stem cell
activation in young mice, could result in subsequent stem cell
depletion, thereby contributing to the decreased articular cartilage
cell density in older mice. NOV is also reported to direct articular
chondrocyte differentiation and inhibit endochondral differentia-
tion38,39. Our data is consistent with this: inappropriate collagen X
staining is seen in Novdel3/ males at 6 months, prior to serious
OA-like pathology.
The Novdel3/ mutant is a new mouse model for OA which
crucially affects multiple tissues of the joint and arises during
ageing, with many features seen in human OA. Importantly, unlike
many other animal models of OA, disease onset is not dependent on
surgical intervention to destabilize the medial meniscus or damage
the ligaments40e42, allowing the involvement of these tissues in OA
progression to be studied. The Novdel3 mutation thus provides a
new model to study joint ageing and degeneration in a known
genetic background, potentially allowing better understanding of
the early changes induced in OA throughout the entire structure of
the joint.
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